Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravitreal and Intracameral DEX in NPDR
Sponsor: Affiliated Hospital of Nantong University
Summary
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Official title: Effect of Intravitreal and Intracameral Injection of Dexamethasone Sodium Phosphate on Mild to Moderate NPDR During Cataract Phacoemulsification
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2022-01-31
Completion Date
2025-06-01
Last Updated
2025-04-30
Healthy Volunteers
No
Conditions
Interventions
Dexamethasone sodium phosphate
In patients with stable DR and no significant macular edema, intravitreal anti-VEGF injections after phacoemulsification surgery can prevent the worsening of postoperative macular edema and potentially improve final visual outcomes while maintaining safety. Laser coagulation and intravitreal anti-VEGF injections are currently considered the standard treatments for PDR. However, the cost of anti-VEGF drugs often prevents many patients from receiving regular and timely injections. Intravitreal corticosteroids may be used as an alternative to anti-VEGF agents.
Locations (1)
Eye Institute, Affiliated Hospital of Nantong University
Nantong, Jiangsu, China